Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J. +1 more·2005·Clinical Infectious Diseases

Cited by (462)

Items 201–300 of 462

  1. Evolutionary conservations, changes of circadian rhythms and their effect on circadian disturbances and therapeutic approaches
    Palm, Denise, Uzoni, Adriana, Simon, Frederick, Fischer, Matthias, Coogan, Andrew, Tucha, Oliver, Thome, Johannes, Faltraco, Frank · 2021 · Neuroscience & Biobehavioral Reviews
  2. Epidemiology of Saccharomyces fungemia: A systematic review
    Kalaiselvi Vinayagamoorthy, Kalyana Chakravarthy Pentapati, Hariprasath Prakash · 2023 · Medical Mycology
  3. Virulence related traits in yeast species associated with food; Debaryomyces hansenii, Kluyveromyces marxianus, and Wickerhamomyces anomalus
    Laura Pérez‐Través, Rosa de Llanos, Allen F. Flockhart, Lydia García-Domingo, Marizeth Groenewald, Roberto Pérez‐Torrado, Amparo Querol · 2021 · Food Control
  4. Effect of Prebiotics on Bacteroides sp. Adhesion and Biofilm Formation and Synbiotic Effect on Clostridioides Difficile
    M Piotrowski, Dorota Wultańska, Hanna M. Pituch · 2022 · Future Microbiology
  5. A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates
    Alexandra Imre, Hanna Viktória Rácz, Zsuzsa Antunovics, Zoltán Rádai, Renátó Kovács, Ksenija Lopandić, István Pócsi, Walter Péter Pfliegler · 2019 · Microbiological Research
  6. Future perspective of probiotics in dermatology: an old wine in new bottle
    Sumir Kumar, Bharat Bhushan Mahajan, Nidhi Kamra · 2014 · Dermatology Online Journal
  7. Preventing necrotising enterocolitis with probiotics
    Carlo Caffarelli, Sergio Bernasconi · 2007 · The Lancet
  8. Ctt1 catalase activity potentiates antifungal azoles in the emerging opportunistic pathogen Saccharomyces cerevisiae
    Dorival Martins, Dao M. Nguyen, Ann M. English · 2019 · Scientific Reports
  9. Yeast: World’s Finest Chef
    Fábio Faria‐Oliveira, Sonia Puga, Celia Ferreir · 2013 · InTech eBooks
  10. N-Alkylated 2,3,3-trimethylindolenines and 2-methylbenzothiazoles. Potential lead compounds in the fight against Saccharomyces cerevisiae infections
    Andrew R. Tyler, Okoh Adeyi Okoh, Clare Louise Lawrence, Vicky C. Jones, Colin Moffatt, Robert B. Smith · 2013 · European Journal of Medicinal Chemistry
  11. Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children
    Şenay Savaş Erdeve, Songül Gökay, Yıldız Bilge Dallar · 2009 · The Turkish Journal of Pediatrics
  12. Antibiotic-Associated Colitis
    Nathan M. Thielman, Kenneth H. Wilson · 2010 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  13. Probiotics, Prebiotics and Synbiotics
    Ravinder Nagpal, Hariom Yadav, Manoj Kumar, Shalini Jain, Yuichiro Yamashiro, Francesco Marotta · 2013 · CRC Press eBooks
  14. Émergence de nouveaux champignons pathogènes en médecine : revue générale
    Dominique Chabasse, Marc Pihet, Jean‐Philippe Bouchara · 2009 · Revue Francophone des Laboratoires
  15. Biochemical characteristics, virulence traits and antifungal resistance of two major yeast species isolated from kefir: Kluyveromyces marxianus and Saccharomyces unisporus
    Hyun‐Woo Lim, Dong‐Hyeon Kim, Dana Jeong, Il‐Byeong Kang, Hyunsook Kim, Kun‐Ho Seo · 2019 · International Journal of Dairy Technology
  16. Septicémie à Saccharomyces cerevisiae chez un prématuré traité par Ultra-Levure®
    Fatma Zohra Chioukh, H. Ben Hmida, K. Ben Ameur, Adnène Toumi, Kamel Monastiri · 2013 · Médecine et Maladies Infectieuses
  17. Infección por Saccharomyces cerevisiae
    Cristine Souza Goebel, Flávio de Mattos Oliveira, Luiz Carlos Severo · 2013 · Revista Iberoamericana de Micología
  18. FUNGEMIA POR SACCHAROMYCES CEREVISIAE EM PACIENTE PEDIÁTRICO APÓS TRATAMENTO COM PROBIÓTICO
    Mariá Ribas Romanio, Ligia Augusto Coraine, Vinicius Pignoti Maielo, Marcelo Luiz Abramczyk, R. R. de Souza, Nilton Ferraro Oliveira · 2017 · Revista Paulista de Pediatria
  19. Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol
    David Schnadower, Phillip I. Tarr, Theron Charles Casper, Marc H. Gorelick, Michael J. Dean, Karen J. O’Connell, Prashant Mahajan, Thomas H. Chun, Seema R. Bhatt, Cindy Ganis Roskind et al. · 2017 · BMJ Open
  20. In Vivo and In Vitro Studies on Virulence and Host Responses to Saccharomyces cerevisiae Clinical and Non-Clinical Isolates
    Alberto Yáñez, Celia Murciano, Silvia Llopis, María Teresa Fernández-Espinar, María Luisa Gil, Daniel Gozalbo · 2009 · The Open Mycology Journal
  21. Saccharomyces cerevisiaeandCandida albicansStimulate Cytokine Secretion from Human Neutrophil-Like HL-60 Cells Differentiated with Retinoic Acid or Dimethylsulfoxide
    Shizue Saegusa, Mamoru Totsuka, Shuichi Kaminogawa, Tomohiro Hosoi · 2009 · Bioscience Biotechnology and Biochemistry
  22. The effect of Lactobacillus bacteria supplement on sepsis and its complications in patients with acute burns
    Lior Koren, Reuven Gurfinkel, R Glezinger, Zvi Howard Perry, Sandra Lev-Ari, Lior Ann Rosenberg · 2007 · Burns
  23. Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains
    Silvia Llopis, Amparo Querol, Antje Heyken, Bernhard Hube, Lene Jespersen, María Teresa Fernández-Espinar, Roberto Pérez‐Torrado · 2012 · BMC Genomics
  24. Baker’s Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress
    Vandana Raghavan, Charles F. Aquadro, Eric Alani · 2019 · Trends in Genetics
  25. Synthesis, Molecular Docking, MEP and SAR Analysis, ADME-Tox Predictions, and Antimicrobial Evaluation of Novel Mono- and Tetra-Alkylated Pyrazole and Triazole Ligands
    Yassine Kaddouri, Btissam Bouchal, Farid Abrigach, Mohamed El Kodadi, Mohammed Bellaoui, Rachid Touzani · 2021 · Journal of Chemistry
  26. The prediction of virulence based on presence of virulence genes in E. coli may not always be accurate
    Trudy M. Wassenaar, Florian Gunzer · 2015 · Gut Pathogens
  27. Epidemiología y prevención de las infecciones nosocomiales causadas por especies de hongos filamentosos y levaduras
    Javier Pemán, Miguel Salavert · 2013 · Enfermedades Infecciosas y Microbiología Clínica
  28. Emergency Department Treatment of Children With Diarrhea Who Attend Day Care: A Randomized Multidose Trial of a <i>Lactobacillus helveticus</i> and <i>Lactobacillus rhamnosus</i> Combination Probiotic
    Freedman, Stephen B., Sherman, Philip M., Willan, Andrew, Johnson, David, Gouin, Serge, Schuh, Suzanne, on behalf of Pediatric Emergency Research Canada (PERC) · 2015 · Clinical Pediatrics
  29. Saccharomyces cerevisiae osteomyelitis in an immunocompetent baker
    Piseth Seng, Alexandre Cerlier, Carole Cassagne, Mathieu Coulange, Regis Legré, Andréas Stein · 2016 · IDCases
  30. Prebiotics, Probiotics, and Synbiotics
    Lea Ann Chen, Cynthia L. Sears · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  31. Linking Antimicrobial Potential of Natural Products Derived from Aquatic Organisms and Microbes Involved in Alzheimer’s Disease - A Review
    Dejan S. Stojković, Marina Kostić, Marija S. Smiljkovic, Milena Aleksić, Perica J. Vasiljevic, Miloš Nikolić, Marina Sokóvić · 2018 · Current Medicinal Chemistry
  32. Invasive fungal infections in cancer patients
    Elias J. Anaissie, Monica Grazziutti, Márcio Nucci · 2009 · Elsevier eBooks
  33. Probiotics, Critical Illness, and Methodologic Bias
    Ronald Lee Koretz · 2009 · Nutrition in Clinical Practice
  34. In Vitro Anti-Oxidant and Anti-Microbial Potentiality Investigation of Different Fractions of Caryota urens Leaves
    Shofiul Azam, Md. Mahmud, Md. Hamza Naquib, Saad Hossain, Mohammad Nurul Alam, Md. Kamal Uddin, Irfan Sajid, Muhammad S Hossain, Md. Salimul Karim, Md. Mahmudul Hasan · 2016 · Biomedicines
  35. Treatment of oral candidiasis (thrush) by Saccharomyces cerevisiae
    Mariappan Premanathan, Fathi Abdullah Amaar Shakurfow, Ahmad Ismail, Mohamed Ayad Berfad, Adel Tawfik Ebrahim, Moussa Milad Awaj · 2011 · International Journal of Medicine and Medical Sciences
  36. First Report of Ventriculoperitoneal Shunt Infection due toCyberlindnera fabianii
    Jonathan D. Baghdadi, Peera Hemarajata, Romney M. Humphries, Theodoros Kelesidis · 2015 · Case Reports in Infectious Diseases
  37. Molecular epidemiology of Saccharomyces cerevisiae in an immunocompromised host unit
    Karl V. Clemons, Juha H Salonen, Jouni Issakainen, JUKKA NIKOSKELAINEN, Michael John McCullough, Jacks Jorge, David A. Stevens · 2010 · Diagnostic Microbiology and Infectious Disease
  38. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics
    Paul O. Lewis, Timothy S. Lundberg, Jennifer L. Tharp, Clay W. Runnels · 2017 · Annals of Pharmacotherapy
  39. Fongémie à Saccharomyces boulardii: méfiez-vous de la levure [Saccharomyces boulardii fungal sepsis: beware of the yeast]
    S. Piechno, Philippe Séguin, Jean‐Pierre Gangneux · 2007 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
  40. Antifungal activities of novel 1,2,3-benzotriazole derivatives synthesized by ultrasonic and solvent-free conditions
    Muvvala S. Sudhir, Venkata Nadh Ratnakaram, Sugreevu Radhika · 2013 · Drug Invention Today
  41. Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
    Shadi Hamoud, Zohar Keidar, Tony Hayek · 2011 · PubMed
  42. Probiotic Products in Canada with Clinical Evidence: What Can Gastroenterologists Recommend?
    Gregor Reid, Kingsley C. Anukam, Tara E. Koyama · 2008 · Canadian Journal of Gastroenterology
  43. Functional Foods and Feeds
    A. Illanes, Cecilia Guerrero · 2016 · Elsevier eBooks
  44. Mycobiome changes in the vitreous of post fever retinitis patients
    Kotakonda Arunasri, Malleswarapu Mahesh, Gumpili Sai Prashanthi, Rajagopalaboopathi Jayasudha, Sama Kalyana Chakravarthy, Mudit Tyagi, Rajeev Reddy Pappuru, Sisinthy Shivaji · 2020 · PLoS ONE
  45. Comparative Genomic Analysis Reveals a Critical Role of De Novo Nucleotide Biosynthesis for Saccharomyces cerevisiae Virulence
    Roberto Pérez‐Torrado, Silvia Llopis, Benedetta Perrone, Rocío Gómez‐Pastor, Bernhard Hube, Amparo Querol · 2015 · PLoS ONE
  46. Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia
    Alexander Tuan Falk, Hélène Raberin, Sandrine Menguy, Denis Guyotat, Nicolas Magné, Jérôme Cornillon, Emmanuelle Tavernier, Camille Devanlay, Aurélie Bourmaud · 2014 · Biomedical Journal
  47. Probiotics in dentistry: A boon or sham.
    Rahul Chopra, Shivani Mathur · 2013 · Europe PMC (PubMed Central) · Retracted
  48. Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection
    Alba Pérez‐Cantero, Pamela Thomson M, Katihuska Paredes, Josep Guarro, Javier Capilla · 2019 · Revista Iberoamericana de Micología
  49. A systems biology approach to the mutual interaction between yeast and the immune system
    Lisa Rizzetto, Duccio Cavalieri · 2010 · Immunobiology
  50. Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy
    Stephen B. Freedman · 2007 · Expert Opinion on Pharmacotherapy
  51. Rare Yeast Infections: Risk Factors, Clinical Manifestations, Treatment, and Special Considerations
    Dana D. Byrne, Annette C. Reboli · 2017 · Current Clinical Microbiology Reports
  52. Saccharomyces: A Friend or Foe in ICU (A Case Report with Solution)
    Akhil Taneja, Prasoon Gupta, YP Singh · 2019 · Indian Journal of Critical Care Medicine
  53. Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute
    Commission For Hospital Hygiene And Infection Prevention (KRINKO) · 2022 · PubMed Central
  54. Light-induced antifungal activity of nanoparticles with an encapsulated porphyrin photosensitizer
    Marie Kodedová, Vojtěch Liška, Jiří Mosinger, Hana Sychrová · 2023 · Microbiological Research
  55. Probiotics and Diverticular Disease
    Anish A. Sheth, Martin H. Floch · 2009 · Nutrition in Clinical Practice
  56. Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly
    Nicolás Dauby · 2017 · Gastroenterology
  57. Therapeutic manipulation of the microbiome in liver disease
    Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan Singh Bajaj · 2024 · Hepatology
  58. Exploring Tenebrio molitor as a source of low‐molecular‐weight antimicrobial peptides using a n in silico approach: correlation of molecular features and molecular docking
    Teresa Gonzalez‐de la Rosa, Elvira Marquez‐Paradas, María José León, Sergio Montserrat‐de la Paz, Fernando Rivero‐Pino · 2024 · Journal of the Science of Food and Agriculture
  59. Furan α-acetoxy methylphosphonates: Design and synthesis, in vitro antibacterial and antifungal activities, DFT, topology exploration (ELF, LOL, RDG) and molecular docking
    Samia Guezane Lakoud, Nourhane Touil, Houda Bouraoui, Fares Hamoud, Hizia Harem, Abdelaziz Ladjimi, Martial Toffano, Yazid Bedouh, Abdelghani Djahoudı · 2024 · Journal of Molecular Structure
  60. Oxidant and antioxidant status in Saccharomyces cerevisiae exposed to antifungal ketoconazole
    Burcu Tongul, Leman Tarhan · 2016 · Process Biochemistry
  61. A Repertoire of the Less Common Clinical Yeasts
    Estelle Menu, Quentin Filori, Jean-Charles Dufour, Stéphane Ranque, Coralie L’Ollivier · 2023 · Journal of Fungi
  62. Saccharomyces cerevisiaeLaryngitis and Oral Lesions in a Patient with Laryngeal Carcinoma
    Jumanah N. Algazaq, Kevan Akrami, Fernando D. Martínez, Allen McCutchan, Ajay Bharti · 2017 · Case Reports in Infectious Diseases
  63. N-alkylated linear heptamethine polyenes as potent non-azole leads against Candida albicans fungal infections
    Clare Louise Lawrence, Okoh Adeyi Okoh, Vinod Vishwapathi, Sean T. McKenna, Megan E. Critchley, Robert B. Smith · 2020 · Bioorganic Chemistry
  64. A contemporary review of Clostridioides difficile infections in patients with haematologic diseases
    Dibyendu Dutta, Firas Muhammad Jafri, DELANEY STUHR, Bettina M. Knoll, Seah H. Lim · 2020 · Journal of Internal Medicine
  65. Prevention of Infection due to Clostridium (Clostridioides) difficile
    Amar Krishna, Teena Chopra · 2021 · Infectious Disease Clinics of North America
  66. Update of Medically Important Yeasts and a Practical Approach to Their Identification
    JoAnn Parker Fenn · 2007 · Laboratory Medicine
  67. Red Regional de Laboratorios para la Vigilancia de las Infecciones Fúngicas Invasoras y Susceptibilidad a los Antifúngicos
    Manuel Cuenca‐Estrella, Juan L. Rodrı́guez-Tudela, Susana Beatriz Córdoba, Márcia de Souza Carvalho Melhem, Maria Walderez Szeszs, Elizabeth Castañeda, Gerardo Martínez, Jean-Marc Gabastou · 2008 · Revista Panamericana de Salud Pública
  68. Isolation method of Saccharomyces cerevisiae from red blood cells based on the optically induced dielectrophoresis technique for the rapid detection of fungal infections
    Mingao Du, Fei Liu, Xiaoli Luan, Gongxin Li · 2021 · Biomedical Optics Express
  69. Saccharomyces cerevisiae boulardii transient fungemia after intravenous self-inoculation
    Lola Cohen, Stéphane Ranque, Didier Raoult · 2013 · Medical Mycology Case Reports
  70. Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit
    Emrah Gün, Halil Özdemir, Dilara Beşli Çelik, Edin Botan, Tanıl Kendirli · 2022 · The Turkish Journal of Pediatrics
  71. Zymomonas mobilis: biomass production and use as a dough leavening agent
    Alida Musatti, Manuela Rollini, Cécilia Sambusiti, Matilde Manzoni · 2014 · Annals of Microbiology
  72. Saccharomyces cerevisiae
    Farhan Farid, Ovais Sideeq, Fazlullah Khan, Kamal Niaz · 2018 · Elsevier eBooks
  73. Consenso chileno de prevención, diagnóstico y tratamiento de la diarrea asociada a Clostridium difficile
    Cristian Hernández-Rocha, Paola C. Pidal, María Cristina Ajenjo, Rodrigo Quera, Marcela Quintanilla, Jaime Lubascher, M. Irene Jemenao, Patricio Ibáñez L, Manuel Álvarez-Lobos, Alexis Diomedi P et al. · 2016 · Revista chilena de infectología
  74. Commercial strain‐derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity
    Walter Péter Pfliegler, Enikő Boros, Kitti Pázmándi, Ágnes Jakab, Imre Zsuga, Renátó Kovács, Edit Zsoldiné Urbán, Zsuzsa Antunovics, Attila Bácsi, Matthias Sipiczki et al. · 2017 · Molecular Nutrition & Food Research
  75. Uncommon Fungi and Related Species
    Duane R. Hospenthal · 2015 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
  76. Sequential laxative-probiotic usage for treatment of irritable bowel syndrome: a novel method inspired by mathematical modelling of the microbiome
    Ming Li, Ri Xu, Yanqing Li · 2020 · Scientific Reports
  77. Probiotics: health safety considerations
    Hemant P. Borase, Mitesh Dwivedi, Ramar Krishnamurthy, Satish V. Patil · 2021 · Elsevier eBooks
  78. Rising environmental temperatures and polluted surface waters: the prelude to the rise of mycoses in South Africa
    Heidi Christa Steffen, Caylin Bosch, Gideon M. Wolfaardt, Alfred Botha · 2022 · Water SA
  79. New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties
    Yassine Kaddouri, Btissam Bouchal, Farid Abrigach, Mohamed El Kodadi, Mohammed Bellaoui, Ahmed Elkamhawy, Rachid Touzani, Magda H. Abdellattif · 2022 · Pharmaceuticals
  80. Infecção por Saccharomyces cerevisae: uma infecção atípica em UTI
    Felipe Henriques Alves da Silva, Fernando Ribeiro Paço, Eduardo P. Reis, Vinícius Henrique Barbosa Amaral · 2011 · Revista Brasileira de Terapia Intensiva
  81. Surveillance of nosocomial fungal infections in a Portuguese paediatric hospital: incidence and risk factors
    Maria Lopes, R. Barros, Isabel Peres, Micaela Serelha, Maria Teresa Neto, José Cabrita, G. Freitas · 2006 · Journal de Mycologie Médicale
  82. A Review of Management of Clostridium difficile Infection: Primary and Recurrence
    Yasmeen Marbaniang Vincent, Arif Manji, Kathleen Gregory-Miller, Christine Lee · 2015 · Antibiotics
  83. The Benefits of Saccharomyces boulardii
    Michael Altmann · 2018 · InTech eBooks
  84. Rapid isolation method of Saccharomyces cerevisiae based on optically induced dielectrophoresis technique for fungal infection diagnosis
    Mingao Du, Gongxin Li, Zhiguo Wang, Yuan Ge, Fei Liu · 2021 · Applied Optics
  85. Biological Activities of SP-A and SP-D Against Extracellular and Intracellular Pathogens
    Hadida Yasmin, Uday Kishore · 2021 · Springer eBooks
  86. Bloodstream infection by Saccharomyces cerevisiae in a COVID-19 patient receiving probiotic supplementation in the ICU in Brazil
    Gabryela Pinto, Lorena Letícia Peixoto de Lima, Thaís Pedra, Adriana Maria Assumpção, Sergio Mascarenhas Morgado, Luiz Affonso Mascarenhas · 2021 · Access Microbiology
  87. Comprehensive Metagenomic Analysis of Veterinary Probiotics in Broiler Chickens
    Kerek, Ádám, Román, István László, Szabó, Ábel, Papp, Márton, Bányai, Krisztián, Kardos, Gábor, Kaszab, Eszter, Bali, Krisztina, Makrai, László, Jerzsele, Ákos · 2024 · Animals
  88. Probiotics: controversial issues
    V. А. Andreev, O. Stetsiouk, I. Andreeva · 2022 · Clinical Microbiology and Antimicrobial Chemotherapy
  89. SACCHAROMYCES CEREVISIAE FUNGAEMIA IN AN IMMUNOCOMPETENT TODDLER
    Despοina Gkentzi, Markos N. Marangos, Ageliki Karatza, Anastasia Spiliopoulou, Anastasia A. Varvarigou, Gabriel Dimitriou · 2020 · Journal of Paediatrics and Child Health
  90. Severe Eosinophilic Syndrome Associated with the Use of Probiotic Supplements: A New Entity?
    Fabian A. Mendoza, Shivani Purohit, Lawrence C. Kenyon, Sergio A. Jiménez · 2012 · Case Reports in Rheumatology
  91. A two-stage microresistive pulse immunosensor for pathogen detection
    Yu Han, Haiyan Wu, Gang Cheng, Jiang Zhe · 2016 · Lab on a Chip
  92. Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro
    Roberto Pérez‐Torrado, Amparo Querol · 2017 · F1000Research
  93. Health Promoting and Disease Preventing Properties of Probiotics with Special Reference to Lactobacillus: A Review
    Ishaq Muhammad, Anum Ali Ahmad, Tariq Shah · 2018 · Journal of Probiotics & Health
  94. Difficult to Treat Infections in the Burn Patient
    Kathryn Lago, Catherine F. Decker, Kevin K. Chung, Dana M Blyth · 2020 · Surgical Infections
  95. Enteric Infections
    Michael S. Wang, Stuart Johnson · 2014 · Cancer treatment and research
  96. The replacement of ergosterol with alternative sterols affects the physiological function of the yeast plasma membrane, including its H+-ATPase activity and resistance to antifungal drugs
    Marie Kodedová, Martin Valachovič, Hana Sychrová · 2024 · Microbes and Infection
  97. Heme Oxygenase-1 (HMX1) Loss of Function Increases the In-Host Fitness of the Saccharomyces ‘boulardii’ Probiotic Yeast in a Mouse Fungemia Model
    Alexandra Imre, Renátó Kovács, Zoltán Tóth, László Majoros, Zsigmond Benkő, Walter Péter Pfliegler, István Pócsi · 2022 · Journal of Fungi
  98. Fungal NOX is an essential factor for induction of TG2 in human hepatocytes
    Yao Huang, Keisuke Fujii, Xinyue Chen, Shun Iwatani, Hiroji Chibana, Soichi Kojima, Susumu Kajiwara · 2019 · Medical Mycology
  99. Molecular identification of non-Cryptococcus yeasts associated with pigeon droppings in Shiraz, Southern Iran.
    Keyvan Pakshir, Zahra Zareshahrabadi, Kamiar Zomorodian, Saham Ansari, Hasti Nouraei, Ali Reza Gharavi · 2019 · PubMed Central
  100. Long-term mortality predictors of ICU fungaemia
    Peng Xie, Wenqiang Wang, Maolong Dong · 2021 · Epidemiology and Infection